Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882
Completed
- Conditions
- Leukemia
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 671
- Registration Number
- NCT00898469
Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia
Withdrawn
- Conditions
- Acute Lymphoblastic LeukemiaUntreated Childhood Acute Lymphoblastic Leukemia
- Interventions
- Other: Pharmacological Study
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Children's Oncology Group
- Registration Number
- NCT00900445
- Locations
- πΊπΈ
Childrens Oncology Group, Philadelphia, Pennsylvania, United States
Study of Tumor Samples From Patients With Ewing Sarcoma
Completed
- Conditions
- Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 200
- Registration Number
- NCT00898053
- Locations
- πΊπΈ
Children's Oncology Group, Monrovia, California, United States
Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia
Completed
- Conditions
- Leukemia
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 150
- Registration Number
- NCT00896766
- Locations
- πΊπΈ
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States
Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate
Completed
- Conditions
- B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionRecurrent Childhood Acute Lymphoblastic LeukemiaT-cell Childhood Acute Lymphoblastic Leukemia
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 150
- Registration Number
- NCT00898404
- Locations
- πΊπΈ
Children's Oncology Group, Arcadia, California, United States
DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Completed
- Conditions
- Leukemia
- Interventions
- Genetic: Southern blottingGenetic: chromosomal translocation analysisGenetic: cytogenetic analysisGenetic: gene rearrangement analysisGenetic: mutation analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 149
- Registration Number
- NCT00899652
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma
Completed
- Conditions
- Ann Arbor Stage I Childhood Hodgkin LymphomaAnn Arbor Stage IV Childhood Hodgkin LymphomaAnn Arbor Stage II Childhood Hodgkin LymphomaAnn Arbor Stage III Childhood Hodgkin LymphomaRefractory Childhood Hodgkin Lymphoma
- Interventions
- Other: Cytology Specimen Collection Procedure
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 1271
- Registration Number
- NCT00900250
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Completed
- Conditions
- Recurrent Adult Non-Hodgkin LymphomaRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Non-Hodgkin Lymphoma
- Interventions
- Other: Cytology Specimen Collection ProcedureOther: Laboratory Biomarker Analysis
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 811
- Registration Number
- NCT00897325
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol SpecificBrain and Central Nervous System TumorsLeukemiaUnspecified Childhood Solid Tumor, Protocol Specific
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2015-10-21
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 53
- Registration Number
- NCT00890435
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Phase 3
Completed
- Conditions
- Myeloid NeoplasmChildhood Acute Promyelocytic Leukemia With PML-RARA
- Interventions
- Other: Diagnostic Laboratory Biomarker Analysis
- First Posted Date
- 2009-03-23
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 106
- Registration Number
- NCT00866918
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States